Annual report pursuant to Section 13 and 15(d)

Related Party Transactions (Details Textual)

v3.7.0.1
Related Party Transactions (Details Textual) - USD ($)
 1 Months Ended 12 Months Ended
Apr. 13, 2016
Jul. 24, 2017
Mar. 31, 2017
Feb. 23, 2017
Dec. 31, 2015
Nov. 30, 2015
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2015
Related Party Transaction [Line Items]                  
Accounts Payable, Related Parties, Current             $ 87,000 $ 200,000  
Research and Development Expense             4,117,000 $ 3,156,000  
Operating Leases, Rent Expense             $ 2,100,000    
Stock Issued During Period, Shares, New Issues 6,500,000                
Common Stock, Par or Stated Value Per Share             $ 0.001 $ 0.001  
Class Of Warrants Or Rights Exercised             0 1,904,000  
Class of Warrant or Right, Exercise Price of Warrants or Rights               $ 0 $ 1.63
Stock Issued During Period, Value, New Issues $ 4,043,000 $ 1,000,000           $ 6,220,000  
Preferred Tracking Stock [Member]                  
Related Party Transaction [Line Items]                  
Stock Issued During Period, Value, New Issues       $ 13,000,000          
Preferred Stock, Par or Stated Value Per Share       $ 0.001          
Convertible Preferred Stock, Shares Issued upon Conversion       29,990,000          
iBio CMO LLC [Member]                  
Related Party Transaction [Line Items]                  
Equity Method Investment, Ownership Percentage       0.01%          
Noncontrolling Interest, Ownership Percentage by Parent       99.99%          
Eastern Two Share Purchase Agreements [Member]                  
Related Party Transaction [Line Items]                  
Stock Issued During Period, Shares, New Issues             10,000,000    
Common Stock, Par or Stated Value Per Share             $ 0.622    
Class Of Warrants Or Rights Exercised             1,784,000    
Class of Warrant or Right, Exercise Price of Warrants or Rights             $ 0.53    
Stock Issued During Period, Value, New Issues             $ 6,220,000    
Eastern Capital Limited and its Affiliates [Member] | Retained Interest [Member]                  
Related Party Transaction [Line Items]                  
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners             70.00%    
Eastern Capital Limited and its Affiliates [Member] | iBio CMO LLC [Member]                  
Related Party Transaction [Line Items]                  
Related Party Transaction, Due from (to) Related Party, Total             $ 15,000,000    
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners             30.00%    
Second Eastern Affilate [Member]                  
Related Party Transaction [Line Items]                  
Accounts Payable, Related Parties, Current             $ 650,000 1,784,000  
Research and Development Expense               565,000  
Interest Expense, Debt             1,928,000 807,000  
Other General And Administrative Expense             $ 775,000 945,520  
Stockholders [Member] | Standstill Agreements [Member]                  
Related Party Transaction [Line Items]                  
Stock Issued During Period, Shares, New Issues             6,500,000    
Director [Member] | Standstill Agreements [Member] | Maximum [Member]                  
Related Party Transaction [Line Items]                  
Equity Method Investment, Ownership Percentage             38.00%    
Novici Biotech LLC [Member]                  
Related Party Transaction [Line Items]                  
Accounts Payable, Related Parties, Current             $ 87,000 200,000  
Research and Development Expense             957,000 1,036,000  
Related Party [Member]                  
Related Party Transaction [Line Items]                  
Operating Leases, Rent Expense     $ 0.53   $ 2,500 $ 2,200 $ 50,000 $ 28,500